Health Catalyst, Inc. financial data

Symbol
HCAT on Nasdaq
Location
South Jordan, UT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 145% % -27%
Debt-to-equity 108% % 5.6%
Return On Equity -30% % -37%
Return On Assets -15% % -34%
Operating Margin -29% % -3.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70,730,884 shares 16%
Common Stock, Shares, Outstanding 70,622,681 shares 16%
Entity Public Float $369,000,000 USD -46%
Weighted Average Number of Shares Outstanding, Basic 70,376,760 shares 16%
Weighted Average Number of Shares Outstanding, Diluted 70,376,760 shares 16%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $316,063,000 USD 4.6%
Research and Development Expense $54,861,000 USD -13%
Selling and Marketing Expense $53,547,000 USD -11%
General and Administrative Expense $54,196,000 USD -4.2%
Operating Income (Loss) $92,274,000 USD -8.4%
Income Tax Expense (Benefit) $962,000 USD
Net Income (Loss) Attributable to Parent $107,622,000 USD -36%
Earnings Per Share, Basic -1 USD/shares -19%
Earnings Per Share, Diluted -1 USD/shares -19%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $40,305,000 USD -88%
Accounts Receivable, after Allowance for Credit Loss, Current $60,109,000 USD 16%
Assets, Current $165,353,000 USD -64%
Property, Plant and Equipment, Net $32,609,000 USD 17%
Operating Lease, Right-of-Use Asset $7,256,000 USD -35%
Intangible Assets, Net (Excluding Goodwill) $89,554,000 USD 17%
Goodwill $285,586,000 USD 22%
Other Assets, Noncurrent $6,770,000 USD 20%
Assets $587,128,000 USD -28%
Accounts Payable, Current $4,943,000 USD -65%
Employee-related Liabilities, Current $5,530,000 USD -44%
Contract with Customer, Liability, Current $58,824,000 USD 13%
Liabilities, Current $87,893,000 USD -73%
Contract with Customer, Liability, Noncurrent $385,000 USD 49%
Operating Lease, Liability, Noncurrent $15,125,000 USD -5.3%
Other Liabilities, Noncurrent $40,000 USD -99%
Liabilities $255,205,000 USD -44%
Common Stocks, Including Additional Paid in Capital $1,604,039,000 USD 5.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,505,000 USD
Retained Earnings (Accumulated Deficit) $1,273,621,000 USD -9.2%
Stockholders' Equity Attributable to Parent $331,923,000 USD -6.5%
Liabilities and Equity $587,128,000 USD -28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $280,000 USD -97%
Net Cash Provided by (Used in) Financing Activities $4,712,000 USD -646%
Net Cash Provided by (Used in) Investing Activities $96,762,000 USD 15%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 70,622,681 shares 16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $92,323,000 USD -2.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $40,305,000 USD -88%
Deferred Tax Assets, Valuation Allowance $268,589,000 USD 19%
Deferred Tax Assets, Gross $277,881,000 USD 19%
Operating Lease, Liability $19,905,000 USD -5.4%
Depreciation $14,300,000 USD 13%
Payments to Acquire Property, Plant, and Equipment $670,000 USD 222%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $106,007,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid $23,664,000 USD -7.6%
Property, Plant and Equipment, Gross $82,093,000 USD 28%
Operating Lease, Liability, Current $3,855,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,591,000 USD 8.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,615,000 USD 7.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) $67,000 USD 379%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,759,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,618,000 USD 11%
Deferred Tax Assets, Operating Loss Carryforwards $194,572,000 USD 26%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $6,818,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,648,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $33,600,000 USD 17%
Deferred Tax Assets, Net of Valuation Allowance $9,292,000 USD 27%
Share-based Payment Arrangement, Expense $33,717,000 USD -20%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%